About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Minneapolis | 338 Studies

Clinical Trials Breast CancerMinneapolis

Breast Cancer Clinical Trials in Minneapolis

Find 338 clinical trials for breast cancer near Minneapolis, Minnesota. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Minneapolis

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 301-320 of 338 trials

TerminatedA Phase 1 Study of [225Ac]-FPI-1434 InjectionThis is a first-in-human Phase 1/2, non-randomized, multi-centre, open-label clinical study designed to investigate safety, tolerability, PK, and preliminary anti-tumour activity…NCT03746431·Duarte, California and 12 others CompletedRadiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast CancerRATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Giving radiation therapy in different ways may kill any tumor cells that remain after surgery.NCT00103181·Birmingham, Alabama and 386 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedFour Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast CancerThis randomized phase III trial studies cyclophosphamide and doxorubicin hydrochloride compared with paclitaxel as adjuvant therapy in treating breast cancer in women with 0-3…NCT00041119·Anniston, Alabama and 526 others

CompletedBreast Cancer Locator Guided vs. Wire Localized Partial Mastectomy for Breast CancerThis prospective, multicenter, 1:1 randomized, controlled trial is designed to evaluate the safety and effectiveness of the Breast Cancer Locator (BCL) in subjects with…NCT04397185·Scottsdale, Arizona and 22 others

CompletedCompass Course: Efficacy StudyThe Compass Course is an 8-session progressive structure that was developed based on theoretical and scientific evidence from psychology and occupational therapy.NCT03442686·Golden Valley, Minnesota and 2 others

CompletedClinical Trial of Trametes Versicolor in Women With Breast CancerRATIONALE: Coriolus versicolor mushroom extract may slow the growth of cancer cells and may be an effective treatment for breast cancer.NCT00680667·Minneapolis, Minnesota and 1 other

CompletedExemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of TamoxifenRATIONALE: Estrogen can stimulate the growth of breast cancer cells.NCT00016432·Huntsville, Alabama and 161 others

CompletedIncidence of Cancer in Women at Increased Genetic Risk of Ovarian CancerThis clinical trial is studying the incidence of cancer in women at increased genetic risk of ovarian cancer.NCT01139957·Birmingham, Alabama and 140 others

CompletedProphylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast CancerThis randomized pilot phase II trial studies and compares prophylactic topical agents in reducing radiation-induced dermatitis in patients with non-inflammatory breast cancer or…NCT02556632·Newark, Delaware and 5 others

CompletedA Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast CancerThis is a 3 arm Phase 3 study to evaluate the safety and efficacy of the addition of veliparib plus carboplatin versus the addition of carboplatin to standard neoadjuvant…NCT02032277·Scottsdale, Arizona and 157 others

RecruitingPembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus PembrolizumabThis phase III trial compares the effect of continuation of treatment with pembrolizumab (usual approach) to observation only at preventing cancer from coming back in patients…NCT05812807·Birmingham, Alabama and 845 others

CompletedStudy Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast CancerThis study evaluated and compared the efficacy and tolerability of lapatinib and letrozole, with letrozole and placebo in post-menopausal women with hormone receptor positive (ER…NCT00073528·Tucson, Arizona and 277 others

Active not recruitingTrastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast CancerThis study will look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast cancer.NCT05113251·Springdale, Arkansas and 144 others

CompletedCombination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast CancerRATIONALE: 1. .NCT00014222·Fort Smith, Arkansas and 77 others

CompletedContinued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast CancerClinical trial in breast cancer patients with bone metastases pretreated for approximately 1 year with a standard zoledronic acid regimen.NCT00320710·Anchorage, Alaska and 91 others

TerminatedStudy of BMS-754807 Combined With Letrozole or BMS-754807 Alone in Patients With Hormone Receptor-Positive Breast Cancer and Resistance to Non-Steroidal Aromatase InhibitorsThe purpose of this study is to evaluate oral doses of BMS-754807 in combination with letrozole or BMS-754807 alone are safe and efficacious in locally advanced or metastatic…NCT01225172·Birmingham, Alabama and 20 others

RecruitingStudy of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe…NCT05633654·Birmingham, Alabama and 377 others

RecruitingShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus TrastuzumabThis phase III trial compares 6 months of human epidermal growth factor receptor 2 (HER2)-targeted therapy to 12 months of HER2-targeted therapy for the treatment of HER2-positive…NCT06876714·Phoenix, Arizona and 701 others

Active not recruitingAn Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)This is a Phase III open-label study to assess if camizestrant improves outcomes compared to standard adjuvant endocrine therapy for patients with ER+/HER2- early breast cancer…NCT05952557·Dothan, Alabama and 660 others

RecruitingI-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerThe purpose of this study is to further advance the ability to practice personalized medicine by learning which new drug agents are most effective with which types of breast…NCT01042379·Birmingham, Alabama and 41 others

PreviousPage 16 of 17Next

Other Conditions in Minneapolis

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma